Greetings From the Editor of Clinical Thyroidology

Abstract

Clinical ThyroidologyVol. 33, No. 1 Greetings from the EditorFree AccessGreetings From the Editor of Clinical ThyroidologyAngela M. LeungAngela M. LeungSearch for more papers by this authorPublished Online:13 Jan 2021https://doi.org/10.1089/ct.2021;33.4-5AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail DEAR COLLEAGUES,Happy New Year to all, and welcome to our first issue of 2021. As we begin this year, we are delighted to announce some new additions to our editorial board. I believe that healthy turnover and the ability to hear fresh perspectives commenting on the hottest topics in the clinical thyroid literature is critical to the rigor of the journal. Thus, I'm pleased to introduce the following individuals as the newest members of our editorial board, each representing a distinct area of expertise within thyroidology: Drs. Juan P. Brito, Ulla Feldt-Rasmussen, Gary L. Francis, Spyridoula Maraka, Donald S.A. McLeod, Lilah F. Morris-Wiseman, Naykky Singh Ospina, Jesse D. Pasternak, and Erivelto Volpi.This year's first issue begins with paired reviews on the topic of congenital hypothyroidism. Drs. Catherine E. Kerr and Gary L. Francis summarize the recently updated guidelines on congenital hypothyroidism published by the European Society for Pediatric Endocrinology and the European Society for Endocrinology, while Drs. Yanrui Huang and Haixia Guan review findings from the Regional Newborn Screening Laboratory of Lombardy, the only laboratory that has been using differential blood-spot TSH cutoffs for newborn screening of congenital hypothyroidism. Regarding the common condition of primary hypothyroidism, Dr. Daniel Toft summarizes a recent systematic review and meta-analysis showing that more than one third of all users of thyroid hormone therapy remain euthyroid after discontinuing the medication, suggesting substantial overtreatment of hypothyroidism.One of our newest editorial board members, Dr. Erivelto Volpi, discusses the experience of a multicenter Italian cohort studying the efficacy of radio-frequency and laser therapy for the treatment of cytologically benign thyroid nodules. This special piece from the expert perspective of Dr. Volpi is part of a collaborative highlight on ablative techniques for thyroid nodules covered recently across the American Thyroid Association's publications program (Thyroid, Video Endocrinology, and Clinical Thyroidology). In his first review for this journal, Dr. Jesse Pasternak reviews a recent study and shares his personal experience highlighting the promise of translaryngeal ultrasound for assessing the vocal cords prior to thyroid surgery.In the area of thyroid cancer, Dr. Tyler Drake reviews a study exploring the pros and cons of considering a terminology change regarding low-risk papillary thyroid cancers. Drs. Yasuhiro Ito, Naoyoshi Onoda, and Akira Miyauchi review a study examining the serum neutrophil-to-lymphocyte ratio as a promising predictor of tumor activity and worsened prognosis in patients with radioiodine-refractory thyroid cancers. Drs. Gunnar Moen and Martin Biermann examine the use of 18F-FDG–PET/CT versus PET/MR imaging, as demonstrated in a recent study from Italy, in localizing suspected persistent and recurrent differentiated thyroid cancer. Finally, I'm pleased that this issue also includes a case report of a young patient with NUT carcinoma of the thyroid, a rare and aggressive thyroid malignancy due to NUT or NUTM1 gene rearrangements that predominantly arises from head, neck, and thoracic structures.As always, thank you to all our readers who are connecting with us through our social media platforms. I invite everyone to join the conversations regarding the content covered in each month's issue and other related topics:Twitter:https://twitter.com/clinicalthyroid (@clinicalthyroid)Facebook:https://www.facebook.com/ThyroidAssociationLinkedIn:https://www.linkedin.com/company/american-thyroid-associationYoutube:https://www.youtube.com/user/thyroidorgAlso, remember that most of the material covered in Clinical Thyroidology is also translated into shorter lay summaries in our sister journal, Clinical Thyroidology for the Public [CTFP] (https://www.thyroid.org/patient-thyroid-information/ct-for-patients), that is edited by Dr. Alan Farwell and his team each month. The summaries in CTFP may be of use to patients and the public who are interested in reading more about recently published studies in the clinical thyroid literature.I hope that each issue provides helpful reviews, commentaries, editorials, and perspectives regarding how best to treat patients with thyroid disease. Guidelines for submitting Letters to the Editor and select Guest Editorials that cover timely and innovative aspects of clinical thyroid disease management may be found at https://home.liebertpub.com/publications/clinical-thyroidologyand174/623/for-authors.Thank you again for your interest in Clinical Thyroidology. Please feel free to send me any questions or comments at clinicalthyroidology@thyroid.org. We are very much looking forward to another great year of bringing you the top highlights in the clinical thyroid literature.Warmest regards,Angela M. Leung, MD, MScEditor-in-Chief, Clinical ThyroidologyFiguresReferencesRelatedDetails Volume 33Issue 1Jan 2021 InformationCopyright 2021 American Thyroid Association, Inc.To cite this article:Angela M. Leung.Greetings From the Editor of Clinical Thyroidology.Clinical Thyroidology.Jan 2021.4-5.http://doi.org/10.1089/ct.2021;33.4-5Published in Volume: 33 Issue 1: January 13, 2021PDF download